Arcline Investment Management Invests in Dark Horse Consulting Group

July 30, 2019

Arcline Investment Management made a growth investment in Dark Horse Consulting Group to support the company's expansion of cGMP products and services for the cell and gene therapy industry. The capital commitment is intended to accelerate Dark Horse's ability to meet rising client demand across manufacturing, regulatory, and CMC consulting.

Buyers
Arcline Investment Management
Targets
Dark Horse Consulting Group
Location
California, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.